CD52-directed Cytolytic Antibody [EPC]
1 drugs in this class with 19,103 total adverse event reports.
1 Drugs
19,103 Total Reports
6,467 Serious Reports
2,899 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Alemtuzumab | ALEMTUZUMAB | 19,103 | 6,467 | 2,899 |